Abstract：
BACKGROUND: Abortion-related complications are among the common causes of maternal mortality in Malawi. Misoprostol is recommended for the treatment of first-trimester incomplete abortions but is seldom used for post-abortion care in Malawi.
METHODS: A descriptive cross-sectional study that used mixed methods was conducted in three hospitals in central Malawi. A survey was done on 400 women and in-depth interviews with 24 women receiving misoprostol for incomplete abortion. Convenience and purposive sampling methods were used and data were analysed using STATA 16.0 for quantitative part and thematic analysis for qualitative part.
RESULTS: From the qualitative data, three themes emerged around the following areas: experienced effects, support offered, and women\'s perceptions. Most women liked misoprostol and reported that the treatment was helpful and effective in expelling retained products of conception. Quantitative data revealed that the majority of participants, 376 (94%) were satisfied with the support received, and 361 (90.3%) believed that misoprostol was better than surgical treatment. The majority of the women 364 (91%) reported they would recommend misoprostol to friends.
CONCLUSIONS: The use of misoprostol for incomplete abortion in Malawi is acceptable and regarded as helpful and satisfactory among women.
One of the major causes of maternal mortality is complications after abortion and miscarriages. The importance of post-abortion care in preventing such deaths justifies the necessity of making treatment accessible and available to every woman in need. Misoprostol is one of the approved treatments for incomplete abortion but is rarely used in developing countries. A study was conducted in three hospitals in central Malawi where women filled in a questionnaire and were interviewed after receiving misoprostol for incomplete abortion. The study\'s goal was to investigate women’s experiences and feelings about using misoprostol. The findings showed that the majority of the women received medication and counselling as a form of support. They expressed satisfaction with the support and described misoprostol as being useful in removing retained products of conception from the womb. The medication was preferred and regarded as a reliable treatment that was also good for women. The majority of the women reported tolerable side effects of the drug and would recommend it to friends. In conclusion, the use of misoprostol for early incomplete abortion in Malawi is acceptable and is regarded as helpful, and satisfactory to women receiving post-abortion care. The research findings support expanding use of misoprostol in post-abortion care in Malawi.
METHODS: A descriptive cross-sectional study that used mixed methods was conducted in three hospitals in central Malawi. A survey was done on 400 women and in-depth interviews with 24 women receiving misoprostol for incomplete abortion. Convenience and purposive sampling methods were used and data were analysed using STATA 16.0 for quantitative part and thematic analysis for qualitative part.
RESULTS: From the qualitative data, three themes emerged around the following areas: experienced effects, support offered, and women\'s perceptions. Most women liked misoprostol and reported that the treatment was helpful and effective in expelling retained products of conception. Quantitative data revealed that the majority of participants, 376 (94%) were satisfied with the support received, and 361 (90.3%) believed that misoprostol was better than surgical treatment. The majority of the women 364 (91%) reported they would recommend misoprostol to friends.
CONCLUSIONS: The use of misoprostol for incomplete abortion in Malawi is acceptable and regarded as helpful and satisfactory among women.
One of the major causes of maternal mortality is complications after abortion and miscarriages. The importance of post-abortion care in preventing such deaths justifies the necessity of making treatment accessible and available to every woman in need. Misoprostol is one of the approved treatments for incomplete abortion but is rarely used in developing countries. A study was conducted in three hospitals in central Malawi where women filled in a questionnaire and were interviewed after receiving misoprostol for incomplete abortion. The study\'s goal was to investigate women’s experiences and feelings about using misoprostol. The findings showed that the majority of the women received medication and counselling as a form of support. They expressed satisfaction with the support and described misoprostol as being useful in removing retained products of conception from the womb. The medication was preferred and regarded as a reliable treatment that was also good for women. The majority of the women reported tolerable side effects of the drug and would recommend it to friends. In conclusion, the use of misoprostol for early incomplete abortion in Malawi is acceptable and is regarded as helpful, and satisfactory to women receiving post-abortion care. The research findings support expanding use of misoprostol in post-abortion care in Malawi.
摘要：
背景：堕胎相关并发症是马拉维孕产妇死亡的常见原因之一。米索前列醇被推荐用于治疗妊娠早期不完全流产，但在马拉维很少用于流产后护理。
方法：在马拉维中部的三家医院进行了使用混合方法的描述性横断面研究。对400名妇女进行了调查，并对24名接受米索前列醇治疗不完全流产的妇女进行了深入访谈。采用了方便和有目的的抽样方法，并使用STATA16.0进行了定量部分和定性部分的主题分析。
结果：根据定性数据，围绕以下领域出现了三个主题：经历的影响，提供支持,和女人的观念。大多数女性喜欢米索前列醇，并报告说这种治疗对排出保留的受孕产品有帮助和有效。定量数据显示，大多数参与者，376人（94%）对获得的支持感到满意，361（90.3%）认为米索前列醇优于手术治疗。大多数364名女性（91％）报告说他们会向朋友推荐米索前列醇。
结论：在马拉维，米索前列醇用于不完全流产是可以接受的，并且被认为是有益的和令人满意的。
孕产妇死亡的主要原因之一是流产和流产后的并发症。堕胎后护理在预防此类死亡方面的重要性证明，有必要为每个有需要的妇女提供治疗。米索前列醇是不完全流产的批准治疗方法之一，但在发展中国家很少使用。在马拉维中部的三所医院进行了一项研究，在接受米索前列醇不完全流产后，妇女填写了问卷并接受了采访。该研究的目的是调查女性使用米索前列醇的经历和感受。调查结果表明，大多数妇女接受药物和咨询作为一种支持形式。他们对支持表示满意，并描述米索前列醇可用于从子宫中去除残留的受孕产物。该药物是首选，并被认为是一种可靠的治疗方法，对女性也有好处。大多数女性报告了这种药物的副作用，并会推荐给朋友。总之,在马拉维，米索前列醇用于早期不完全流产是可以接受的，并且被认为是有帮助的，对接受堕胎后护理的妇女感到满意。研究结果支持在马拉维的流产后护理中扩大米索前列醇的使用。
方法：在马拉维中部的三家医院进行了使用混合方法的描述性横断面研究。对400名妇女进行了调查，并对24名接受米索前列醇治疗不完全流产的妇女进行了深入访谈。采用了方便和有目的的抽样方法，并使用STATA16.0进行了定量部分和定性部分的主题分析。
结果：根据定性数据，围绕以下领域出现了三个主题：经历的影响，提供支持,和女人的观念。大多数女性喜欢米索前列醇，并报告说这种治疗对排出保留的受孕产品有帮助和有效。定量数据显示，大多数参与者，376人（94%）对获得的支持感到满意，361（90.3%）认为米索前列醇优于手术治疗。大多数364名女性（91％）报告说他们会向朋友推荐米索前列醇。
结论：在马拉维，米索前列醇用于不完全流产是可以接受的，并且被认为是有益的和令人满意的。
孕产妇死亡的主要原因之一是流产和流产后的并发症。堕胎后护理在预防此类死亡方面的重要性证明，有必要为每个有需要的妇女提供治疗。米索前列醇是不完全流产的批准治疗方法之一，但在发展中国家很少使用。在马拉维中部的三所医院进行了一项研究，在接受米索前列醇不完全流产后，妇女填写了问卷并接受了采访。该研究的目的是调查女性使用米索前列醇的经历和感受。调查结果表明，大多数妇女接受药物和咨询作为一种支持形式。他们对支持表示满意，并描述米索前列醇可用于从子宫中去除残留的受孕产物。该药物是首选，并被认为是一种可靠的治疗方法，对女性也有好处。大多数女性报告了这种药物的副作用，并会推荐给朋友。总之,在马拉维，米索前列醇用于早期不完全流产是可以接受的，并且被认为是有帮助的，对接受堕胎后护理的妇女感到满意。研究结果支持在马拉维的流产后护理中扩大米索前列醇的使用。
